Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Jan 28, 2023; 15(1): 10-19
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.10
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.10
Advancements of molecular imaging and radiomics in pancreatic carcinoma
Xiao-Xi Pang, Liang Xie, Xiu-Xia Liu, Department of Nuclear Medicine, The Second Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China
Wen-Jun Yao, Department of Radiology, The Second affiliated hospital of Anhui Medical University, Hefei 230601, Anhui Province, China
Bo Pan, PET/CT Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, Anhui Province, China
Ni Chen, Department of Nuclear Medicine, School of Basic Medicine Anhui Medical University, Hefei 230032, Anhui Province, China
Author contributions: Pang XX and Xie L wrote the paper; Pan B provided cases of 18F-FDG vs 18F-FAPI PET/CT scan and advice on 18F-FDG vs 18F-FAPI of pancreatic carcinoma; Yao WJ and Liu XX provided advice on MRI scan of pancreatic carcinoma; Chen N and Pang XX cooperated on scientific research in Gd-DOTA-HHK and 99mTc-DOTA-HHK compounds.
Supported by The Basic and Clinical Cooperative Research Promotion Plan of Anhui Medical University , No. 2019xkjT011 ; Anhui Provincial Natural Science Foundation , No. 2008085QH406 ; and Anhui Medical University Joint Project of Nuclear Medicine and Radiation Medicine , No. 2021 Lcxk035 .
Conflict-of-interest statement: The authors have declared that no conflicts of interest exist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ni Chen, Department of Nuclear Medicine, School of Basic Medicine Anhui Medical University, No. 81 Meishan Road, Hefei 230032, Anhui Province, China. icefei@mail.ustc.edu.cn
Received: September 30, 2022
Peer-review started: September 30, 2022
First decision: October 29, 2022
Revised: November 12, 2022
Accepted: January 9, 2023
Article in press: January 9, 2023
Published online: January 28, 2023
Peer-review started: September 30, 2022
First decision: October 29, 2022
Revised: November 12, 2022
Accepted: January 9, 2023
Article in press: January 9, 2023
Published online: January 28, 2023
Core Tip
Core Tip: Pancreatic carcinoma remains high incidence and poor prognosis. Molecular imaging enables early and precise diagnosis, efficient assessment, non-invasive pathological classification. This paper aims to review the recent research progress of nuclear medicine, magnetic resonance imaging and radiomics in the diagnosis of pancreatic carcinoma, and also briefly describe our team's work in this field.